Amundi Has $2.29 Million Position in HealthEquity, Inc. $HQY

Amundi grew its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY) by 690,625.0% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 27,629 shares of the company’s stock after acquiring an additional 27,625 shares during the period. Amundi’s holdings in HealthEquity were worth $2,292,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of HQY. Adage Capital Partners GP L.L.C. boosted its position in shares of HealthEquity by 50.0% during the 1st quarter. Adage Capital Partners GP L.L.C. now owns 12,000 shares of the company’s stock worth $1,060,000 after purchasing an additional 4,000 shares in the last quarter. EP Wealth Advisors LLC boosted its position in shares of HealthEquity by 17.9% during the 1st quarter. EP Wealth Advisors LLC now owns 5,372 shares of the company’s stock worth $475,000 after purchasing an additional 817 shares in the last quarter. Ashford Capital Management Inc. boosted its position in shares of HealthEquity by 2.1% during the 1st quarter. Ashford Capital Management Inc. now owns 274,999 shares of the company’s stock worth $24,302,000 after purchasing an additional 5,687 shares in the last quarter. Baird Financial Group Inc. bought a new position in shares of HealthEquity during the 1st quarter worth about $848,000. Finally, Clough Capital Partners L P boosted its position in shares of HealthEquity by 133.9% during the 1st quarter. Clough Capital Partners L P now owns 87,000 shares of the company’s stock worth $7,688,000 after purchasing an additional 49,800 shares in the last quarter. 99.55% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at HealthEquity

In other HealthEquity news, EVP Michael Henry Fiore sold 1,794 shares of HealthEquity stock in a transaction that occurred on Monday, July 7th. The shares were sold at an average price of $101.73, for a total transaction of $182,503.62. Following the transaction, the executive vice president owned 53,225 shares of the company’s stock, valued at $5,414,579.25. This trade represents a 3.26% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 1.50% of the stock is currently owned by corporate insiders.

HealthEquity Price Performance

Shares of NASDAQ HQY opened at $92.34 on Friday. HealthEquity, Inc. has a fifty-two week low of $74.07 and a fifty-two week high of $116.65. The stock has a market cap of $7.96 billion, a price-to-earnings ratio of 55.96, a PEG ratio of 1.31 and a beta of 0.50. The company has a debt-to-equity ratio of 0.47, a quick ratio of 4.23 and a current ratio of 4.23. The firm’s 50-day simple moving average is $93.60 and its 200 day simple moving average is $94.60.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on the stock. JPMorgan Chase & Co. increased their price objective on shares of HealthEquity from $125.00 to $126.00 and gave the stock an “overweight” rating in a research report on Wednesday, September 3rd. Barrington Research reissued an “outperform” rating and set a $125.00 price objective on shares of HealthEquity in a research report on Friday, August 29th. Jefferies Financial Group increased their price objective on shares of HealthEquity from $130.00 to $134.00 and gave the stock a “buy” rating in a research report on Wednesday, September 3rd. JMP Securities increased their price objective on shares of HealthEquity from $110.00 to $117.00 and gave the stock a “market outperform” rating in a research report on Wednesday, June 4th. Finally, Deutsche Bank Aktiengesellschaft increased their price objective on shares of HealthEquity from $98.00 to $115.00 and gave the stock a “buy” rating in a research report on Thursday, June 5th. One analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat, HealthEquity currently has a consensus rating of “Buy” and a consensus target price of $119.77.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.